Technology News and Research

RSS

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Halozyme Therapeutics, Inc. today announced a global collaboration and license agreement with Eli Lilly and Company to develop and commercialize products combining proprietary Lilly compounds with Halozyme's ENHANZE platform.

21 Dec 2015

Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference

Chromatrap, a business unit of Porvair Sciences, has announced that it will be the Lead Sponsor at the prestigious “Epigenetics in Drug Discovery” conference to be held in Cambridge, UK from 26th-27th January 2016.

From Chromatrap® - Porvair Sciences Ltd 21 Dec 2015

Anytime Fitness acquires PumpOne

Anticipating the needs and preferences of current and future gym members, Anytime Fitness announced today that it has purchased PumpOne – a leading mobile personal training services provider featuring the world's largest exercise image and video library.

21 Dec 2015

New study improves understanding of metal-based chemotherapy drugs

What is the mechanism of action of metal-based chemotherapy drugs (the most widely used for treating common cancers like testicular or ovarian cancer)? How can we improve their effect and reduce their toxicity? A new study combining experiments and theory has broadened our knowledge of the molecular mechanisms of these active drugs to help experimentalists devising increasingly effective drugs with fewer side effects.

21 Dec 2015

Roche's cobas HIV-1 viral load test approved by FDA for use on cobas 6800 and cobas 8800 Systems

Roche announced today that it has received FDA approval for the cobas HIV-1 viral load test by the United States Food and Drug Administration for use on the cobas 6800 and cobas 8800 Systems. This HIV-1 viral load test is part of the next generation of Roche viral load tests, which clinicians use to manage the disease and treatment of patients infected with HIV-1.

21 Dec 2015

CMFT adopts ZedScan system to improve cervical cancer care

DP Medical Systems Ltd has secured a deal with Central Manchester University Hospitals NHS Foundation Trust (CMFT) to adopt ZedScan™ as part of its cervical cancer care pathway.

From Zilico 21 Dec 2015

TUM scientists develop small molecule that may allow future patient-specific treatment of cancer tumours

Integrins help cells communicate with and adapt to their environment. Also cancer cells depend on their properties to survive and spread throughout the body. Now scientists at the Technical University of Munich have successfully developed a small, highly active molecule that binds to a specific integrin which operates in many types of cancer.

21 Dec 2015

Certain gut bacteria linked to type 2 diabetes, reveal Russian scientists

A group of Russian scientists, including Dr Elena Kostryukova, the Head of the Laboratory of Postgenomic Research in Biology of the Scientific Research Institute of Physical-Chemical Medicine and a researcher at MIPT (Moscow Institute of Physics and Technology), and Maria Vakhitova, an MIPT postgraduate student, has discovered that the presence of certain bacteria in the gut may be linked to the development of type 2 diabetes.

21 Dec 2015

Researchers invited to showcase latest advances in surgical robot technologies at Surgical Robot Challenge

The world’s pioneering researchers in robotic surgery are invited to showcase their innovative work by taking part in the Surgical Robot Challenge 2016. The Surgical Robot Challenge is open for entry from today, and the competition finals will be held from 20 – 27 June 2016 at the Hamlyn Symposium on Medical Robotics in London, as part of the first ever UK Robotics Week.

21 Dec 2015

Protelhealth CEO urges entrepreneurs, technology innovators to prevent challenges faced by ageing population

How to care for the oldest members of society is a pressing issue for the global economy but, despite their fast growing numbers and obvious need of support to remain independent, they are being neglected by technological innovators according to the Chief Executive Officer of new healthcare technology business.

21 Dec 2015

MorphoSys implements Dotmatics’ Vortex to improve antibody research

Dotmatics, a leading provider of scientific informatics solutions and services, announced MorphoSys will implement Vortex to analyse and visualise their screening data enabling rapid, informed decision making. MorphoSys choose Vortex because of the intuitive nature of the product and its extensive drug discovery capabilities.

21 Dec 2015

Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients

Adaptimmune Therapeutics plc, a leader in the use of TCR engineered T-cell therapy to treat cancer, today announced that it has initiated a Phase I/II study of its affinity enhanced T-cell therapy targeting the MAGE-A10 cancer antigen in patients with locally advanced or metastatic (Stage IIIb or IV) non-small cell lung cancer (NSCLC), the most prevalent type of lung cancer representing approximately 85 percent of lung cancers.

21 Dec 2015

Variant signs worldwide exclusive license and development agreement with L&F Research

Variant Pharmaceuticals, Inc., an emerging pharmaceutical company focusing on rare diseases and other specialty conditions with limited or sub-optimal therapeutic options, announced today a worldwide exclusive license and development agreement with L&F Research LLC to advance development of Variant's lead product, VAR 200.

20 Dec 2015

GSI Group purchases SkyeTek assets for $2.6 million

GSI Group Inc., a global leader and supplier of laser, precision motion, and vision technologies to original equipment manufacturers ("OEM") in the medical and advanced industrial markets, today announced it has acquired the assets of SkyeTek, a Denver, Colorado-based provider of embedded and standalone RFID Solutions for medical OEM's for $2.6 million in cash, subject to customary working capital adjustments.

20 Dec 2015

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Janssen Pharmaceuticals, Inc. announced today that the company has entered into a definitive collaboration and license agreement with Bavarian Nordic to leverage their MVA-BN technology, jointly with Janssen's own AdVac® technology, in the development and commercialization of a heterologous prime-boost vaccine for the treatment of Human Papillomavirus (HPV) chronic infections which can lead to cancer.

20 Dec 2015

Synthetic biomaterial aids in regeneration of skin cells to improve wound healing

Some skin wounds, such as diabetic ulcers, are chronic and may never heal; others, such as burn wounds, are often large and difficult to treat, resulting in pain, infection and scarring. Researchers at the University of California, Los Angeles, funded by the National Institutes of Health, have developed a synthetic biomaterial that fills wounds and aids in regeneration of skin cells, which ultimately improves wound healing.

18 Dec 2015

Minority groups in the U.S. less likely than white people to trust doctors

When it comes to trust in their physicians, minority groups in the United States are less likely than white people to believe their doctors care about them, according to research by University of Pennsylvania's Abigail Sewell.

18 Dec 2015

AES Annual Meeting takes our understanding of epilepsy to next level

Epilepsy remains one of the most common neurological conditions, affecting one in 26 Americans in their lifetime, with one-third having a form of the condition that resists treatment or effective management. With those statistics in mind, more than 5,200 neurologists, scientists, nurses and health professionals came to Philadelphia December 4-8 for the 2015 American Epilepsy Society Annual Meeting to discuss new discoveries and emerging technologies that can lead to more effective treatment.

18 Dec 2015

More effort needed to reduce risks of mosquito-transmitted epidemics in the U.S. and Mexico

Despite the increasing risks of mosquito-transmitted epidemics in the United States and Mexico, policymakers in both countries have made little effort to prevent future outbreaks, according to a new policy brief by tropical-disease and science policy experts at Rice University's Baker Institute for Public Policy.

18 Dec 2015

UA developing brain-scanning technology that could improve diagnosis of many disorders

Researchers at the University of Arizona are developing a noninvasive brain-scanning technology that could produce images far superior to those obtained with the most commonly used systems -- electroencephalography and functional magnetic resonance imaging.

17 Dec 2015

Technology News and Research

Halozyme Therapeutics, Lilly sign global collaboration and license agreement

Chromatrap to be Lead Sponsor at 'Epigenetics in Drug Discovery' conference

Anytime Fitness acquires PumpOne

New study improves understanding of metal-based chemotherapy drugs

Roche's cobas HIV-1 viral load test approved by FDA for use on cobas 6800 and cobas 8800 Systems

CMFT adopts ZedScan system to improve cervical cancer care

TUM scientists develop small molecule that may allow future patient-specific treatment of cancer tumours

Certain gut bacteria linked to type 2 diabetes, reveal Russian scientists

Researchers invited to showcase latest advances in surgical robot technologies at Surgical Robot Challenge

Protelhealth CEO urges entrepreneurs, technology innovators to prevent challenges faced by ageing population

MorphoSys implements Dotmatics’ Vortex to improve antibody research

Adaptimmune begins Phase I/II study of affinity enhanced T-cell therapy targeting MAGE-A10 in NSCLC patients

Variant signs worldwide exclusive license and development agreement with L&F Research

GSI Group purchases SkyeTek assets for $2.6 million

Janssen collaborates with Bavarian Nordic to develop, commercialize vaccine for chronic HPV infections

Synthetic biomaterial aids in regeneration of skin cells to improve wound healing

Minority groups in the U.S. less likely than white people to trust doctors

AES Annual Meeting takes our understanding of epilepsy to next level

More effort needed to reduce risks of mosquito-transmitted epidemics in the U.S. and Mexico

UA developing brain-scanning technology that could improve diagnosis of many disorders

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News